Galapagos (GLPG)
(Delayed Data from NSDQ)
$32.56 USD
-0.32 (-0.97%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $32.56 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Galapagos NV has a market cap of $1.75B, which represents its share price of $26.55 multiplied by its outstanding shares number of 65.90M. As a small-cap company, GLPG's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
GLPG 32.56 -0.32(-0.97%)
Will GLPG be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GLPG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GLPG
Galapagos (GLPG) Loses -21.19% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Biotech Stock Roundup: REGN's Drug Approval, LXRX, RYTM Stocks Gain on Update & More
GLPG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Galapagos (GLPG) Up on FDA Nod to Begin Phase I/II Lymphoma Study
Other News for GLPG
Galapagos (GLPG) Secures RMAT Status for Innovative Cancer Therapy
Galapagos granted RMAT designation to GLPG5101 by FDA
Galapagos (GLPG) Downgraded by Deutsche Bank with New Price Target
Galapagos (GLPG) Downgraded to Sell Amid Uncertainty
Deutsche Bank downgrades Galapagos to Sell amid 'too much uncertainty'